Aug 10
|
Veru Reports Fiscal 2023 Third Quarter Financial Results
|
Apr 12
|
Down -51.21% in 4 Weeks, Here's Why You Should You Buy the Dip in Veru Inc. (VERU)
|
Apr 11
|
Once COVID-19 Candidate, Veru's Sabizabulin Shows Encouraging Action In Animal Studies Against Poxvirus
|
Apr 11
|
Veru Announces Preclinical Study Results that Demonstrate Sabizabulin Inhibits Poxviruses
|